ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Weicker Ready To Fight for Increased NCI, NIH Funding, Objects to Limits On Grants, Positions

March 14, 1986

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Funding opportunities listed.

February 27, 2004

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004